Skip to main content
VCbacked
Log inGet Started

Aelix Therapeutics

Barcelona, Spain

Aelix Therapeutics develops therapeutic vaccines and immunotherapies to treat HIV infection.

$2.2M raised
Sep 2021
Venture - Series Unknown
BiotechnologyHealth CareTherapeutics

Top Investors

Ysios CapitalEIT HealthJohnson & Johnson Robotics and Digital SolutionsCDTICriteria Venture Tech

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Aelix Therapeutics

How much funding has Aelix Therapeutics raised?
Aelix Therapeutics has raised $2.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2021.
Who are Aelix Therapeutics's investors?
Aelix Therapeutics's investors include Ysios Capital, EIT Health, Johnson & Johnson Robotics and Digital Solutions, CDTI, Criteria Venture Tech.
Where is Aelix Therapeutics headquartered?
Aelix Therapeutics is headquartered in Barcelona, Spain.
What does Aelix Therapeutics do?
Aelix Therapeutics develops therapeutic vaccines and immunotherapies to treat HIV infection.
What stage is Aelix Therapeutics at?
Aelix Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Aelix Therapeutics — Funding & Investors." VCBacked, September 16, 2021, https://www.vcbacked.co/company/aelix-therapeutics. Accessed July 3, 2026.
APA
VCBacked. (2021). Aelix Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/aelix-therapeutics
Wikipedia (cite web)
{{cite web |title=Aelix Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aelix-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K